P0417: Impact of Cytomegalovirus infection on patients with Inflammatory Bowel Disease in the Southern Area of Gran Canaria: a case-control study.ECCO'25Year: 2025
Authors: Peñate BolañosPhD, M.(1)*;Tosco-Nuñez, T.(2);Hernández Expósito, N.(1);Rodríguez Castellot, J.(1);Ciordia Nalda, I.(1);Alemán Gonzalez, H.(1);Quevedo Ruano, R.(3);Monescillo Francia, A.(1);
(1)Hospital Universitario Insular de Gran Canaria, Servicio de Aparato Digestivo, Las Palmas de Gran Canaria, Spain;(2)Hospital Universitario Insular de Gran Canaria, Servicio de Microbiología, Las Palmas de Gran Canaria, Spain;(3)Hospital Universitario Insular de Gran Canaria, Servicio Aparato Digestivo, Las Palmas de Gran Canaria, Spain;
1.Dutta S, Ray U. Cytomegalovirus (CMV) as a cause of exacerbation of ulcerative colitis (UC). An approach to diagnosis and management. Indian Journal of Medical Microbiology. noviembre de 2023;46:100469.
2. Kwon J, Fluxá D, Farraye FA, Kröner PT. Cytomegalovirus-related colitis in patients with inflammatory bowel disease. International Journal of Colorectal Disease. 1 de marzo de 2022;37(3):685-91.
3. Mourad FH, Hashash JG, Kariyawasam VC, Leong RW. Ulcerative Colitis and Cytomegalovirus Infection: From A to Z. Journal of Crohn’s and Colitis. 7 de septiembre de 2020;14(8):1162-71.
4. Hazır-Konya H, Avkan-Oğuz V, Akpınar H, Sağol Ö, Sayıner A. Investigation of Cytomegalovirus in Intestinal Tissue in a Country With High CMV Seroprevalence. Turk J Gastroenterol. 1 de febrero de 2021;32(2):123-32.
P0418: The implementation of IBD-dedicated multidisciplinary healthcare pathway improves patients’ satisfaction and reduces disability in patients with IBDECCO'25Year: 2025
Authors: Buisson, A.(1)*;Banana Hamadidi, A.(1);Dumas, V.(1);Dodel, M.(1);Coban, D.(1);Bazoge, M.(1);Rivière, C.(1);Heux, J.(1);Pereira, B.(1);
(1)CHU Clermont-Ferrand, IBD Unit, Clermont-Ferrand, France;
P0419: Impact of psychopathology and gut-microbiota on disease progression in Ulcerative Colitis: a five-year follow-up studyECCO'25Year: 2025
Authors: D'Onofrio, A.M.(1);Chiera, E.(2)*;Gomez-Nguyen, A.(3);Di Vincenzo, F.(4);Spagnolo, G.(5);Ferrarese, D.(5);Cammarota, G.(4);Camardese, G.(1);Scaldaferri, F.(4);
(1)Fondazione Policlinico Universitario "A. Gemelli" IRCCS- Università Cattolica del Sacro Cuore, Department of Neuroscience- Psychiatry Unit, Roma, Italy;(2)Università Cattolica del Sacro Cuore, Department of Translational Medicine and Surgery, Roma, Italy;(3)Digestive Health Research Institute- Case Western Reserve University, Department of Medicine, Cleveland, United States;(4)Fondazione Policlinico Universitario "A. Gemelli" IRCCS- Università Cattolica del Sacro Cuore, CEMAD Digestive Disease Center, Roma, Italy;(5)Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Clinical Psychology Unit, Roma, Italy;
P0420: Interim analysis of real-world-data on PROs and biomarker remission collected through the Health Outcome Observatory (H2O) consortium in IBD patientsECCO'25Year: 2025
Authors: Novacek, G.(1)*;Fierens, L.(2);Primas, C.(1);Ferrante, M.(2);Schreiner, P.(1);Borruel, N.(3);Serra, X.(3);Dabsch, S.(1);Schilling, V.(1);Frick, A.(1);Reinisch, W.(1);Schweiger, K.(1);Galan, G.(4);Ferri, M.(4);Ritschl, V.(5);Mosor, E.(5);Long, P.(5);Winkler, E.(1);Mooslechner, T.(1);Wisniowski, K.(1);Kazemi-Shirazi, L.(1);Bäuerle, M.(1);Dejaco, C.(1);Stamm, T.(5);
(1)Medical University of Vienna, Department of Internal Medicine III, Vienna, Austria;(2)Catholic University Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)Hospital Universitari Vall d'Hebron, Crohn's and Colitis Attention Unit, Barcelona, Spain;(4)Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institut de Recerca VHIR, Barcelona, Spain;(5)Medical University of Vienna, Institute for Outcome Research, Vienna, Austria;
1Fierens L, Carney N, Novacek G, van der Woude CJ, Siegmund B, Casellas F, Borruel N, Huberts AS, Sonnenberg E, Gerold N, Primas C, Hedin CRH, Stamm T, Julsgaard M, Fiorino G, Radice S, Zini MLL, Gross E, Sander C, Arijs I, Vakouftsi VR, Koltai T, Health Outcomes Observatory H O Patient Advisory Board For Inflammatory Bowel Diseases, Health Outcomes Observatory H2O Steering Committee, Charlafti I, Ferrante M. A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process. J Crohns Colitis. 2024 Oct 15;18(10):1583-1595. doi: 10.1093/ecco-jcc/jjad195. PMID: 38019894.
P0421: Clinical validity of a seroproteomic index of endoscopic activity in pediatric Crohn's diseaseECCO'25Year: 2025
Authors: Orlanski Meyer , E.(1);Dotson , J.(2);Saeed , S.(3);Zitomersky , N.(4);Focht , G.(1)*;Rabizadeh , S.(5);Sockolow , R.(6);Griffiths , A.(7);Navas-López , V.M.(8);Sladek , M.(9);Baldassano , R.(10);Otley , A.(11);Spencer , E.(12);Ho , J.(13);Dervieux , T.(13);Turner , D.(1);Dubinsky , M.(12);
(1)Shaare Zedek Medical Center, Gastroenterology, Jerusalem, Israel;(2)University of Arkansas for Mediical Sciences, Gastrorenterology, Little Rock, United States;(3)Wright State University Boonshoft School of Medicine, Gastroenterology, Dayton, United States;(4)Boston Children’s Hospital, Gastroenterology, Boston, United States;(5)Cedars Sinai Medical Center, Gastroenterology, Los Angeles, United States;(6)Weill Cornell University, Gastroenterology, New York, United States;(7)Hospital for Sick Children, Gastroenterology, Toronto, Canada;(8)University Hospital of Málaga, Gastroenterology, Malaga, Spain;(9)kademickie Centrum Komputerowe Cyfronet AGH, Gastroenterology, Krakow, Poland;(10)The Children's Hospital of Philadelphia, Gastroenterology, Philadelphia, United States;(11)IWK health, Gastroenterology, Halifx, Canada;(12)Mount Sinai Kravis Children’s Hospital, Gastroenterology, New York, United States;(13)Prometheus Laboratories, Research and Development, San Diego, United States;
